CVS Health declared its intention to separate into two distinct publicly traded entities by the first half of 2028, marking a significant departure from its strategy of building an integrated healthcare conglomerate. The split would divide the company’s approximately 9,000 retail pharmacies from its insurance operations and Caremark, one of the nation’s three largest pharmacy benefit managers. This decision reverses the company’s $78 billion acquisition of Aetna completed in 2018.
The announcement came following a comprehensive strategic review by CVS’s board of directors. The insurance and pharmacy benefit management company will retain the CVS Health name and continue under CEO David Joyner’s leadership, while the retail pharmacy division will operate as CVS Pharmacy under Prem Shah, currently group president of CVS Health. Existing shareholders will own stock in both companies following the separation. The company stated that the split would enable both entities to pursue focused strategic agendas with greater capacity for innovation and efficiency improvements.
CVS reported that the decision stems from a position of strength, citing recovery in Aetna’s Medicare business and solid retail pharmacy performance. The company’s shares declined more than 12 percent following the announcement, despite posting third-quarter earnings and revenue that exceeded Wall Street expectations, with total sales reaching $108.40 billion. The company has been executing a turnaround strategy involving $2 billion in cost reductions, store closures, and leadership changes since Joyner assumed the chief executive role in October 2024.
The breakup addresses growing legislative scrutiny regarding vertical integration in healthcare. Pharmacy benefit managers face increasing bipartisan political attention over pricing transparency and market consolidation concerns. Several states have passed laws restricting co-ownership of PBMs and pharmacies, with legal challenges currently underway. CVS has indicated that commercial agreements between the two successor companies will preserve key synergies despite the operational separation.
Article Attribution | Read More at Article Source
Article summary produced by Claude AI